» Articles » PMID: 23565383

FRAX: Facts and Fantasy

Overview
Specialty Endocrinology
Date 2013 Apr 9
PMID 23565383
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

FRAX is an important web based tool to assess fragility fracture risk in osteoporosis. It has many important limitations too. Good clinical judgement is needed to interpret the results of FRAX. With increasing use we can improvise this tool further.

Citing Articles

Osteoporosis in Indian Patients Undergoing Elective Arthroplasty and Spinal Procedures: An Observational Study.

Dave D, Bhattacharjee S, Shah D, Mascerhans A, Dey P, Arumugan S Cureus. 2022; 14(7):e27275.

PMID: 35910701 PMC: 9329657. DOI: 10.7759/cureus.27275.


Predictors of Imminent Risk of Nonvertebral Fracture in Older, High-Risk Women: The Framingham Osteoporosis Study.

Hannan M, Weycker D, McLean R, Sahni S, Bornheimer R, Barron R JBMR Plus. 2019; 3(6):e10129.

PMID: 31346561 PMC: 6636767. DOI: 10.1002/jbm4.10129.


Bone turnover markers: Emerging tool in the management of osteoporosis.

Shetty S, Kapoor N, Bondu J, Thomas N, Paul T Indian J Endocrinol Metab. 2016; 20(6):846-852.

PMID: 27867890 PMC: 5105571. DOI: 10.4103/2230-8210.192914.


Type 1 diabetes and osteoporosis: A review of literature.

Dhaon P, Shah V Indian J Endocrinol Metab. 2014; 18(2):159-65.

PMID: 24741510 PMC: 3987264. DOI: 10.4103/2230-8210.129105.


National health programs in the field of endocrinology and metabolism - Miles to go.

Shriraam V, Mahadevan S, Anitharani M, Selvavinayagam , Sathiyasekaran B Indian J Endocrinol Metab. 2014; 18(1):7-12.

PMID: 24701424 PMC: 3968736. DOI: 10.4103/2230-8210.126521.

References
1.
Silverman S, Calderon A . The utility and limitations of FRAX: A US perspective. Curr Osteoporos Rep. 2010; 8(4):192-7. PMC: 2947011. DOI: 10.1007/s11914-010-0032-1. View

2.
Dawson-Hughes B, Tosteson A, Melton 3rd L, Baim S, Favus M, Khosla S . Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008; 19(4):449-58. DOI: 10.1007/s00198-008-0559-5. View

3.
Watts N, Ettinger B, LeBoff M . FRAX facts. J Bone Miner Res. 2009; 24(6):975-9. DOI: 10.1359/jbmr.090402. View

4.
Tosteson A, Melton 3rd L, Dawson-Hughes B, Baim S, Favus M, Khosla S . Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008; 19(4):437-47. PMC: 2729707. DOI: 10.1007/s00198-007-0550-6. View

5.
Brown J, Josse R . 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002; 167(10 Suppl):S1-34. PMC: 134653. View